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Abstract
Multidrug-resistant Salmonella enterica serovar Typhimurium ST313 has emerged in sub-Saharan Africa causing severe
infections in humans. Therefore, it has been speculated that this specific sequence type, ST313, carries factors associated
with increased pathogenicity. We assessed the role in virulence of a gene with a yet unknown function, st313-td, detected in
ST313 through comparative genomics. Additionally, the structure of the genomic island ST313-GI, harbouring the gene was
determined. The gene st313-td was cloned into wild type S. Typhimurium 4/74 (4/74-C) as well as knocked out in S.
Typhimurium ST313 02–03/002 (Dst313-td) followed by complementation (02-03/002-C). Dst313-td was less virulent in mice
following i.p. challenge than the wild type and this phenotype could be partly complemented in trans, indicating that st313-
td plays a role during systemic infection. The gene st313-td was shown not to affect invasion of cultured epithelial cells,
while the absence of the gene significantly affects uptake and intracellular survival within macrophages. The gene st313-td
was proven to be strongly associated to invasiveness, harboured by 92.5% of S. Typhimurium blood isolates (n = 82) and
100% of S. Dublin strains (n = 50) analysed. On the contrary, S. Typhimurium isolates of animal and food origin (n = 82) did
not carry st313-td. Six human, non-blood isolates of S. Typhimurium from Belarus, China and Nepal harboured the gene and
belonged to sequence types ST398 and ST19. Our data showed a global presence of the st313-td gene and in other
sequence types than ST313. The gene st313-td was shown to be expressed during logarithmic phase of growth in 14
selected Salmonella strains carrying the gene. This study reveals that st313-td plays a role in S. Typhimurium ST313
pathogenesis and adds another chapter to understanding of the virulence of S. Typhimurium and in particular of the
emerging sequence type ST313.
Citation: Herrero-Fresno A, Wallrodt I, Leekitcharoenphon P, Olsen JE, Aarestrup FM, et al. (2014) The Role of the st313-td Gene in Virulence of Salmonella
Typhimurium ST313. PLoS ONE 9(1): e84566. doi:10.1371/journal.pone.0084566
Editor: Jose´ A. Bengoechea, Queen’s University Belfast, United Kingdom
Received September 5, 2013; Accepted November 23, 2013; Published January 3, 2014
Copyright:  2014 Herrero-Fresno et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: This work was funded by the Center for Genomic Epidemiology (www.genomicepidemiology.org) and by the World Health Organization Global
Foodborne Infections Network (www.who.int/gfn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the
manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: ahefr@sund.ku.dk
Introduction
Worldwide, nontyphoidal salmonellae (NTS) are a major cause
of foodborne illness and commonly cause self-limiting gastroen-
teritis. The ubiquitous Salmonella enterica serovar Typhimurium,
which affects both humans and animals, is one of the most
commonly reported NTS serovars [1]. Thus, globally, it ranked as
the first (North America and Oceania) and the second (rest of the
world) most common serovar in the period from 2007 to 2011 [1].
Bloodstream or focal infections caused by NTS are infrequent
in developed countries [2] and mainly occur in individuals with
specific risk factors [3]. In developing countries, NTS frequently
cause severe illness, invasive infections, and even death especially
among young children with underlying diseases or among HIV-
infected immunocompromised adults [4,5]. NTS are among the
most common bacterial pathogens involved in invasive disease in
sub-Saharan Africa, causing bacteraemia and meningitis with a
mortality rate of 20–25% [3,6–9]. Recently, a highly invasive
multidrug-resistant S. Typhimurium of a distinct MultiLocus
Sequence Type (MLST), ST313, has emerged in several African
countries and represents a major public health concern [10–12].
Next Generation Sequencing (NGS) studies have revealed that
S. Typhimurium ST313 is a clonal clade presently circulating in
sub-Saharan Africa introduced by a common ancestry more than
50 years ago [13]. The clade has recently been divided up into
two lineages which have acquired similar resistance genes on
separate occasions [14]. Genomic degradation was identified in
the sequenced genome of S. Typhimurium ST313 D23580
compared to other S. Typhimurium chromosomes [10]. This
included the presence of pseudogenes, deletions (some linked to
virulence) and a novel repertoire of prophage elements. Kingsley
et al. [10] suggest that the evolution of the auxiliary genome of S.
Typhimurium may be of clinical significance, increasing the
invasiveness of the bacteria. Additionally, such partial selective
genome degradation could potentially also lead to host adapta-
tion to humans as described for host restricted serovars such as S.
Typhi, S. Paratyphi A and S. Gallinarum [10]. For these reasons,
S. Typhimurium ST313 D23580 has been extensively used in
studies on host pathogen interaction to gain more knowledge
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about NTS infection and to elucidate the reason for the apparent
increased pathogenicity of this clone [15–19]. Some of these
studies suggest that S. Typhimurium ST313 might have adapted
to occupy an ecological and immunological niche provided by
HIV, malaria and malnutrition in Africa [11].
Several works have linked S. Typhimurium ST313 to invasive
disease [10–21], however, none has so far identified potential
virulence determinants responsible for this disease. Virulence
factors of S. Typhimurium are conveniently studied in the mouse
model, where S. Typhimurium causes a systemic typhoid-like
infection. Additionally, various in vitro cell culture models have
proven useful for the analysis of molecular mechanisms during
host-pathogen interaction in S. enterica infections [22].
The pathogenesis triggered by S. Typhimurium has been
extensively studied over the last few years and genome studies,
involving the application of cutting-edge NGS technologies, have
been highly useful for a better understanding of differences
between strains. So far, genes encoded from Salmonella pathoge-
nicity islands (SPIs) have been reported as the most significantly
factors contributing to host cell interactions [23,24]. Additional
virulence determinants, such as those encoded within the pSLT
virulence plasmid, adhesins, flagella, and biofilm-related proteins,
are also under study and have been found to be involved in several
stages of the disease [25–29].
In a recent work we have identified a putative virulence
associated gene designated st313-td (924 pb) through comparative
genomics. This gene, of unknown function and unique to S.
Typhimurium ST313 and S. Dublin, is harboured in a putative
uncharacterized genomic island termed ST313-GI of ,18 kb in
the S. Typhimurium ST313 genomes. Among the genes of
unknown function contained in ST1313-GI, st313-td, was the
only one present in both, ST313 and Dublin chromosomes [12].
The aim of this study was to assess the role of the gene st313-td
from S. Typhimurium ST313 in virulence. In addition, the
presence, frequency as well as the expression of the putative
virulence gene was estimated in strains of S. Typhimurium and S.
Dublin from a global strain collection. Furthermore, the genomic
structure of the genomic island ST313-GI in S. Typhimurium
ST313 was revealed.
Materials and Methods
Ethical statement
The clinical investigation has been conducted according to the
principles expressed in the Declaration of Helsinki. Mice infection
studies were performed with permission to John Elmerdahl Olsen
from the Danish Animal Experiments Inspectorate, license
number 2009/561–1675.
Bioinformatics analyses
Open reading frames (ORFs) of the genomic island ST313-GI
were determined using the gene finder named Prodigal [30].
Information available at NCBI (www.ncbi.nlm.nih.gov) and the
Uniprot database (www.uniprot.org) were used to determine the
putative role of the ST313-GI encoded proteins. The analysis of
the GC content and map construction of ST313-GI were
performed with the Clone Manager Suite 9.0 software.
Bacterial strains and growth conditions
From a global strain collection maintained at the National Food
Institute of the Technical University of Denmark (DTU-Food), a
total of 295 S. Typhimurium and 50 S. Dublin isolates from 10
countries were analysed for the presence of the gene st313-td
(Table 1). Eighty-two (27.8%) out of the 295 S. Typhimurium
strains were associated to bacteraemia (isolated from blood
specimens) whereas the remaining isolates (72.2%) originated
from other sources such as food, stools etc.
S. Typhimurium 02–03/002 was used in all the experiments
conducted in this study representing the clone S. Typhimurium
ST313. This strain was isolated from a bacteremic child in the
region of Lwiro (Democtratic Republic of Congo) in 2002–2003
[12]. The S. Typhimurium non-ST313 strains, 4/74 and 14028,
were used as controls in the different assays. The virulence
properties of 4/74 and 14028 have been previously described
[31,32].
The isolates were inoculated in Luria-Bertani broth or plates
(LB) (Oxoid) and incubated for 16 h at 37uC. In addition to these
conditions, broths were shacked at 200 rpm during incubation. If
necessary, the LB medium was supplemented with antimicrobials
at the following concentrations: kanamycin (50 mg/mL), apramy-
cin (75 mg/mL), gentamicin (25 mg/mL) (Sigma).
Table 1. Salmonella strains analysed for the presence of st313-td.
Salmonella serovar (N) Origin /specimena (N) Country of originb (N) st313-td (N)
S. Typhimurium (295) Human blood (82) Congo (74), Mauritius (6), Zambia (2) 76
Human stools (117) Belarus (35), Mauritius (26), China (56) 39
Animal (73) Thailand (30), Denmark (43) 0
Food (9) Mauritius (5), Thailand (1), Ethiopia (3) 0
Others (14) Nepal (9), Thailand (4), Congo (1) 6
S. Dublin (50) Human (25) Denmark (50) 50
Cattle (25)
All the strains were collected between the years 2000 and 2011. Isolates were serotyped in Denmark or Thailand as previously described [35,55,56]. The strain collection
is conserved at DTU –Food (Technical University of Denmark).
aThe animals strains were collected from poultry (N = 50), pig (N = 22) and shrimp (N= 1).
b29 out of the 82 isolates from Congo were previously described [56]. 16 strains from Mauritius (N = 1 from blood, N= 2 from food and N= 13 from stools) were
associated to the same outbreak [57]. The isolates from Belarus, China and Nepal (all them isolated from water) were also published elsewhere [33,34,35].
doi:10.1371/journal.pone.0084566.t001
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Detection of the gene st-313-td in S. Typhimurium and S.
Dublin strains
The presence of the gene st313-td was evaluated by PCR using
the primers st313-td-F and st313-td-R (TAG Copenhagen A/S)
(Table S1). The following conditions were used for the amplifica-
tion: 5 min at 94uC; 30 cycles of 1 min at 94uC, 30 sec at 55uC,
and 1 min at 72uC; terminating with one cycle of 10 min at 72uC.
The isolate 02–03/002 served as positive control, providing an
amplicon of 1029 pb, whereas 4/74 was used as negative control.
Whole genome sequencing, multilocus sequence typing
and identification of Single Nucleotide Polymorphisms
(SNPs)
Six S. Typhimurium strains collected in Belarus (S. Typhimur-
ium 1093 and S. Typhimurium 133, isolated from stools) [33],
China (S. Typhimurium 2006–130 and S. Typhimurium 2007–
024, from stools) [34], and Nepal (S. Typhimurium B1 and S.
Typhimurium D12, from water) [35] (Table 1) harbouring the
gene st313-td, were sequenced by Illumina GAIIx genome
analyzer (Illumina, Inc., San Diego, CA). The raw reads were
subsequently submitted to the European Nucleotide Archive
(www.ebi.ac.uk/ena/) under accession no. ERP004195. The raw
reads can be accessed freely from the following link; http://www.
ebi.ac.uk/ena/data/view/PRJEB4869. Assembly was performed
by using the pipeline available on the Center for Genomic
Epidemiology (www.genomicepidemiology.org). The latter is
based on Velvet; algorithms for de novo short reads assembly [36].
MultiLocus Sequence Typing (MLST) was performed on the six
isolates according to MLST Databases: http://mlst.ucc.ie/.
SNPs were identified as previously described [12] using the S.
Typhimurium ST313 D23580 genome as a reference. A SNP tree
showing the divergence/relatedness of the Salmonella Typhimur-
ium strains carrying st313-td, assigned to different ST types is
shown in Figure S1.
Expression studies
Bacteria were grown to logarithmic phase in LB (OD600nm
= 0.460.01). RNA was isolated from 1.5 ml aliquots of overnight
cultures by mechanical disruption with the FastPrep system
(Bio101; Q-biogene) and by using the RNeasy mini kit (Qiagen).
Quantity and quality of total RNA was determined with the
NanoDrop 1000 spectrophotometer (Thermo Scientific). The
RNA was DNase treated with the TURBOTM DNase and
reverse transcribed with the High Capacity cDNA Reverse
Transcription Kit (Applied Biosystems) following the supplier’s
recommendations. The qPCR was done with the Maxima SYBR
Green/Rox qPCR Master Mix and gene specific oligonucleotides
(Table ) in a MxPro3000 cycler. The gene rsmC [37] was used as
reference.
Construction of strains and plasmids
The wild type strains (WT) and plasmids used for the cloning
and mutagenesis experiments as well as the mutated isolates
constructed are listed in Table 2.
The mutagenesis of 02–03/002 for the gene st313-td was
performed using Lambda Red Mediated Recombination as
previously described by Datsenko and Wanner [38] leading to
the isogenic strain Dst313-td. Since the WT strain was resistant to
ampicillin, a derivative conferring gentamicin resistance (encoded
by the gene aac(3)-Id) of the helper plasmid pKD46 was used [39].
Selection of mutants was performed on LB agar plates supple-
mented with apramycin (75 mg/mL). Apramycin selection was
carried out because the isolate 02–03/002 harbors the gene
aac(69)-Iaa (conferring resistance to Kanamycin). The apramycin
resistance-encoding gen (aac(3)IV) was amplified from the plasmid
pUO9090 (M.C. Martı´n, unpublished results). The resulting
construct, Dst313-td, was verified by PCR for the absence of the
gene st313-td.
The PCR amplicon corresponding to the gene st313-td obtained
from 02-03/002 was cloned into the restriction endonuclease site
Table 2. Strains and plasmids used for mutagenesis and derived isolates.
Strains and plasmids Relevant features Reference
S. Typhimurium strains
02–03/002 Wild type ST313, st313-td-positive strain 12
4/74 Wild type. Virulent reference strain 31
14028 Wild type. Virulent reference strain ATCC
KP1274 Restriction deficient strain 41
02-03/002-E 02–03/002, pACY177, KnR This work
Dst313-td Dst313-td, AprR This work
02-03/002-C Dst313-td, pACY177+st313-td (pAHF4), AprR, KnR This work
4/74-E 4/74, pACY177, KnR This work
4/74-C 4/74, pACY177+st313-td (pAHF4), KnR This work
invH201::TnphoA invH mutant, KnR 46
DssaV ssaV mutant, SPI2-T3SS defect, KnR 45
Plasmids
pACY177 Cloning vector, ApR, Kn
R 40
pAHF4 pACY177 expressing st313-td This work
pKD46-Gn Plasmid with l red recombinase expressed from arabinose inducible
promoter and gentamicin resistance gene aac(3)-Id
39
pUO9090 AprR Unpublished
doi:10.1371/journal.pone.0084566.t002
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ScaI-PstI of the vector pACY177 [40] giving rise to the plasmid
pAHF4. The promoter of the Ampicillin cassette present in the
vector was used to ensure the expression of st313-td. The presence
of the insert was confirmed by PCR and restriction endonuclease
assays. The restriction deficient strain Escherichia coli KP1274 was
used as primary recipient for plasmids [41]. Competent cells of
KP1274 were prepared and electroporated according to standard
conditions [42] using the recombinant vector mentioned above
and the pACY177 insert-free plasmid. Transformants were
selected from LB agar plates containing kanamycin (50 mg/mL)
and plasmids with and without the insert were purified and re-
electroporated into the competent strain of 4/74. The selection of
the transformants was conducted as previously indicated and the
resulting mutated strains were named 4/74-E (harbouring the
insert-free plasmid pACY177) and 4/74-C (containing the
recombinant vector pAHF4). Both constructs were verified by
plasmid analysis, restriction endonuclease assays and PCR. The
primers used for the cloning and mutagenesis of st313-td are listed
in Table S1.
After being recovered from KP1274 competent cells, the
plasmid pAHF4 was also electroporated into Dst313-td competent
cells in order to obtain the complemented strain 02-03/002-C.
Analysis of the growth of WT and genetic manipulated
strains in LB
The WT and the mutated strains (Table 2) were assessed for the
ability to grow in LB media. The isolates were grown at 37uC,
200 rpm for 16 h in LB before sub-culturing into fresh media at a
40 fold dilution and further grown with assessments every 15 min
for 18 h using Bioscreen C. A growth curve for each of the strains
was obtained and growth was similar between the mutant and WT
strains reaching the stationary phase after approximately 6–8 h
post-inoculation (not shown).
Mouse mixed infections
Infections of female six-week old C57/BL6 mice were
performed as described by Jelsback et al. [43]. Briefly, groups
of five mice each were inoculated i.p. with 0.1 ml of a 1:1
mixture of the WT and the mutated bacteria grown to stationary
phase, suspended in physiological saline. The inocula were
prepared as follows; WT and mutated isolates were grown for
16 h, 200 rpm at 37uC in LB. The WT and mutant strains were
mixed before the infection to provide a challenge dose of 56103
bacteria of each strain. The CFU and ratio between WT and
mutated isolates were enumerated by plating as described [43].
Mice were killed at six days post-inoculation by cervical
dislocation. Severely affected animals were sacrificed earlier for
animal welfare reasons, but otherwise treated as the rest of the
group. The spleens were removed aseptically and bacteria
recovered. Ten-fold dilutions series were prepared and plated
on LB agar plates and CFU counts were performed. One
hundred colonies were randomly picked and tested for antimi-
crobial resistance to the relevant compounds (Apramycin 75 mg/
mL or Kanamycin 50 mg/mL) to determine the proportion of
the mutant strains. The competitive index (CI) was calculated
based on the ratio of the mutant/WT from the spleen in relation
to the mutant/WT ratio of the inoculum. A CI = 1 indicates that
the virulence of the strains tested is equal. A CI,1 shows that
the mutant is less virulent than the WT.
Infection of macrophages
The role of the gene st313-td in the intracellular survival and
replication within mouse macrophages was investigated using
J774.1 cells; a mouse monocyte-derived macrophage-like cell line
as previously described [44] with modifications. The isolate
14028 and the isogenic strain DssaV were used as positive and
negative control for the infection assays, respectively. The latter
Figure 1. Genetic structure of ST313-GI. The genomic organization is shown with a scale in kb. Arrow above the scale represents predicted ORFs
and their transcription directions. ORF 21 corresponds to the virulence gene st313-td and is highlighted with a rectangle. Twenty-one ORFs encode
phage-related functions: integration and excision: int and xis, respectively, Ea region: eaa and eae, recombination: abc2 (Anti-RecBCD), erf and kil,
regulatory functions: reg, structural: gp54, anti-restriction: ral, inmunity: c1 (repressor) and cro (antirepressor), transcription: ta (transcriptional
activator), replication: repl, Nin region: nin, antitermination: Q (Q protein). The sequence data have been extracted from the sequenced genome of the
strain S. Typhimurium D23580, accession no. FN424405.1. The location of ST313-GI within this genome is 368767_386754. The location of st313-td is;
377825_378748 (locus_tag= ’’STMMW_03531’’ and protein id: ‘‘YP_005231421.1’’). All the genes within ST313-GI have been annotated in the genome
of D23580. The function of the encoded proteins was determined by using the Uniprot database (http://www.uniprot.org/). See additional Table S2
for more details.
doi:10.1371/journal.pone.0084566.g001
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is deficient in ssaV, a structural component of the SPI2-encoded
T3SS [45] reducing its rate of intracellular replication with
regard to the WT.
Briefly, macrophage cells were cultured in RPMI+Gluta-
MAXTM-I, Earles, 25 mM HEPES (Gibco) supplemented with
10% (v/v) heat-inactivated FBS and 25 mg/mL gentamicin. Cells
were incubated in a humidified 37uC, 5% CO2 incubator. The
bacteria were grown in LB to a stationary phase, harvested at
8000 rpm for 5 min and resuspendeded in 0.9% (w/v) NaCl.
Complement-opsonisation of the bacteria prior to infection, if
used, was performed by mixing the bacteria with mouse serum
followed by incubation at 37uC for 20 min. Bacteria were added
at a multiplicity of infection of 10:1 (bacteria complement-
opsonized) or 50:1 (bacteria not opsonized). Monolayers were
centrifuged at 300 rpm for 5 min immediately after addition of
the bacteria followed by incubation for 25 min at 37uC, 5%
CO2. Enumerations of the bacteria in the inoculum were verified
by plating onto LB agar plates (counted before infection). After
infection, the media was removed and monolayers were washed
twice with 0.9% NaCl. At this point (defined as time 0 h) fresh
media containing 250 mg/mL amikacin was added to kill the
extracellular bacteria. The plates were incubated for 1 h at 37uC,
5% CO2 before new media supplemented with 100 mg/mL
amikacin was added for the remaining part of the experiment.
This high concentration was used to ensure the killing of
extracellular bacteria (lower concentrations did not always kill
100% of the extracellular population after 20 h). To enumerate
the bacteria, cells were washed twice with 0.9% NaCl,
subsequently lysed in 1 ml 0.1% Triton X-100 (v/v). The viable
intracellular bacteria were enumerated by colony counts of lysate
dilutions plated on LB agar plates. For intracellular survival,
bacteria were enumerated at t = 1 h (survival 1 h post-uptake),
and t = 20 h (survival/replication 20 h post-infection). When
opsonization was not performed, only survival after 1 h post-
uptake (t = 1 h) was measured. Values determined at t = 20 h
were expressed relatively to CFU for the WT determined at T1.
The experiments were carried out in quadruplicates.
Macrophage cytotoxicity assay
Cytotoxcity was assessed by measuring the release of cytosolic
lactate dehydrogenase (LDH) into the supernatants as previously
described [44] with modifications. J774 cells were incubated with
bacteria for a 25 min infection period and then cultured in
medium containing 250 mg/mL amikacin for 1 h and 100 mg/
mL for the remaining part of the assay (as described for the
infection assays). At both times, t = 1 h and t = 20 h post-uptake,
the culture supernatants of infected cells were collected,
transferred to 96-well plates, and their LDH levels were
measured using the colorimetric Cytotox 96 kit (Promega). The
relative LDH release was calculated as 1006 (experimental
release – spontaneous release)/(total release – spontaneous
release) where spontaneous release is the amount of LDH
activity in the supernatant of uninfected J774 cells and total
release is the activity in cell lysates.
Infection of epithelial cell lines
The association between the gene st313-td and the invasion of
the human epithelium was analysed using Int-407 cells (HeLa-
derived epithelial cells). The isolate 4/74 and the isogenic strain
invH201::TnphoA [46] were used as positive and negative control
for the infection assays, respectively. The latter has a mutation in
the invH gene, reducing its rate of invasion with regard to the WT
strain.
The epithelial cells were cultivated in ‘‘Eagle Minimum
Essential medium’’ MEM+ GlutaMAXTM-I, Earles, 25 mM
HEPES (Gibco) supplemented with 10% (v/v) heat-inactivated
fetal bovine serum (FBS, Invitrogen) and 25 mg/mL gentamicin to
prevent bacterial contamination. The cells were grown statically in
a humidified 37uC, 5% CO2 incubator. Twenty-four hours prior
to infection, the Int-407 cells were seeded in 24-well plates in a
concentration of 56105 cells per well and left under the mentioned
conditions. The bacteria were grown for 16 h, 200 rpm, 37uC in
LB and sub-cultured (,107 CFU/mL) into fresh LB and
incubated for additional 3 h. At this point, when the bacteria
reached an OD600,0.5, the cultures were centrifuged at
6000 rpm for 5 min. The bacteria were resuspended to
OD600 = 1.0 (16109 bacteria per ml) in 0.9% NaCl and added
to monolayers at a multiplicity of infection of 100:1 (bacteria to
eukaryotic cell). Equal inoculum counts were verified by plating on
LB agar plates (counts before infection). After 1 h of infection at
37uC, 5% CO2, the media was removed and monolayers were
washed twice with 0.9% NaCl. At this point, fresh media
containing 250 mg/mL amikacin was added to kill extracellular
bacteria. The plates were incubated for further 2 h at 37uC, 5%
CO2. To enumerate invaded bacteria (t = 2 h), cells were washed
twice with 0.9% NaCl and lysed in 1 ml 0.1% Triton X-100 (v/v).
The viable intracellular bacteria were enumerated by colony
counts of lysate dilutions plated on LB agar. The experiments were
performed in quadruplicates.
Statistical analysis
Statistical significance of the differences between the strains was
determined using the GraphPad Prism 6.1 program. In all the
assays, the statistical significance (P values) was determined by one-
way ANOVA analysis with pair-wise comparison of means by
using Tukey’s multiple comparison test.
Results
Genetic structure of the genomic island ST313-GI
In a previous study we showed that the gene st313-td is located
within a potential pathogenicity island ST313-GI in S. Typhimur-
Table 3. Competitive index analysis of S. Typhimurium
mutants.
Salmonella strains Competitive index (CI)
WT 02/03–002
versus
Dst313-td (4) 0,0124a
02-03/002-C (4) 0,3340b
WT 4/74
versus
4/74-C (4) 1,5251a
CI = 1: the virulence of the strains tested is equal.
CI,1: the mutant is less virulent than the WT.
aCI was significantly different from 1.0 (P value ,0.001).
bCI was significantly different from corresponding mutant (P value .0.05).
Competition indices were calculated based on input (CFU/mL of inoculum) and
output.
(CFU/mL of spleen sample) numbers of wild type versus mutant bacteria as
previously.
described [43]. The results are shown as means values based on the number of
mice tested.
(indicated in brackets).
doi:10.1371/journal.pone.0084566.t003
Role of st313-td in Virulence of S. Typhimurium
PLOS ONE | www.plosone.org 5 January 2014 | Volume 9 | Issue 1 | e84566
ium ST313 [12] as illustrated in Figure 1. In the present work, we
further characterized this genomic island through in silico studies.
The sequence of ST313-GI to determine its structure has been
extracted from the publicly available and annotated genome of
D23580 (accession no. FN424405.1). It is to note that the gene
island is not contained within any of the five prophages described
in the mentioned genome. ST313-GI, of 17836 bp, is flanked by
tRNA genes encoding for threonine (Thr) at the 39end, and
asparagine (Asn) and threonine, at the 59 end, respectively. Such
integration between tRNA encoding genes has typically been
described for genomic islands in bacterial chromosomes [47]. In
addition, the overall G+C content is 45.7%, which equals that of
Salmonella phages and other genomic islands [23,48]. The genomic
island ST313-GI consists of 38 Open Reading Frames (ORFs) of
which 17 encode unknown functions or predicted phage proteins
based on the NCBI annotated analysis and the Uniprot database.
Among these 17 ORFs, ORF21 corresponds to the gene st313-td.
The remaining 21 ORFs of ST313-GI encode phage-related
functions, such as replication, integration, excision etc. (Figure 1,
Table S2).
Distribution of the st313-td gene among strains of S.
Typhimurium and S. Dublin
The presence of the gene st313-td was determined by PCR in
295 S. Typhimurium of unknown MLST and 50 S. Dublin
isolates, which were selected from a global strain collection.
Seventy-six (92.7%) out of the 82 S. Typhimurium strains from
blood specimens exhibited the amplicon corresponding to the gene
st313-td (Table 1). In contrast, the gene was less frequently found
in the 213 S. Typhimurium strains collected from other sources
and only 45 (21.1%) displayed the band expected for st313-td. The
latter included 32 and seven isolates originated from stools in
Belarus [33] and China [34], respectively and six strains from
sewer water in Nepal [35]. It is noteworthy, that st313-td gene was
absent in the remaining 168 (78.9%) non-blood S. Typhimurium
isolates, including those collected from animals (n = 73) and food
(n = 9) (Table 1). On the other hand, all the 50 (100%) S. Dublin
strains from human (n = 25) and cattle (n = 25) harboured the
st313-td gene (Table 1).Thus, results derived from PCR revealed
that the gene st313-td is mainly associated to invasive strains of
Salmonella.
st313-td is associated to MLST types of S. Typhimurium
different from ST313
We assessed whether the non-blood S. Typhimurium strains
carrying st313-td belonged to the lineage ST313. Thus, six non-
invasive S. Typhimurium isolates representing a wide geograph-
ical distribution and positive for the gene st313-td were subjected
to whole genome sequencing to assign a specific MLST type.
None of the six strains from Belarus, China and Nepal belonged
to ST313. Thus, the four non-blood isolates from Belarus and
Nepal were assigned to the MLST ST328, while the remaining
two non-blood isolates from China belonged to ST19 which is
one of the predominant S. Typhimurium genotype in the MLST
database (http://mlst.ucc.ie/). MLST ST313 differs from ST19
at only one MLST locus (sucA), which in turns differs from
ST328 at the locus aroC [49]. These data indicate certain
genetically relatedness among the isolates. A SNP tree showing
the relatedness/divergence between the representative strains
assigned to the different MLST types of S. Typhimurium
Figure 2. Infection of J774 mouse macrophages. Intracellular survival/replication, A) at t = 1 h post-infection with opsonisation, B) at t = 1 h
post-infection without opsonisation, and C) at t = 20 h post-infection with opsonisation, and with regards to t = 1 h post-uptake (the intracellular
survival at t = 1 h for all the tested isolates is regarded as 1.0). Strains tested were: S. Typhimurium WT 02–03/002, 4/74 and 14028 and the mutant
isolates: Dst313-td, 02-03/002-C (pAHF4, complemented strain), 4/74-C (pAHF4) and DssaV. The experiments were repeated at least 4 times with
similar results and shown is an average of these. Errorbars indicate standard deviation. Statistical significance (**** = P,0,00001; ** = P,0,001) was
determined by one-way ANOVA analysis with pair-wise comparison of means.
doi:10.1371/journal.pone.0084566.g002
Role of st313-td in Virulence of S. Typhimurium
PLOS ONE | www.plosone.org 6 January 2014 | Volume 9 | Issue 1 | e84566
carrying st313-td is illustrated in Figure S2. The analysis revealed
that the strains clustered in two separate groups. One group
included strains of African origin (assigned to ST313) and the
second group contained strains from Asia and Europe (assigned
to ST19 or ST328). These two groups of strains could either
have a common st313-td ancestor or the gene could have been
transferred independently into the two groups from another
source.
Analysis of the expression of the gene st313-td
In order to study whether the st313-td gene was actually
expressed in the different isolates where we had detected the gene,
RT-qPCR was performed on a selection of strains. The collection
included; two strains of S. Dublin (from cattle and human,
respectively) and 12 strains of S. Typhimurium (two from each of
the countries where st313-td-positive isolates were identified and
belonging to the ST types so far detected as carriers of st313-td;
ST313, ST19 and ST328) (Table 1, Figure S2). The gene was
shown to be expressed in all the strains tested at early logarithmic
phase of growth in LB (data not shown).
The genomic island ST313-GI containing st313-td is
apparently restricted to S. Typhimurium ST313
To study whether st313-td was always harboured within
ST313-GI, in silico studies were performed to determine the
presence of the gene island in the publicly available genomes
containing the gene. In a previous study, ST313-GI was shown
to be restricted to S. Typhimurium ST313 strains collected in
sub-Saharan Africa [12] (unpublished data). Thus, ST313-GI
was not found in the two S. Dublin chromosomes available in
Genbank (accession no. CP001143 and CM001151). In these
genomes, only a fragment of ,6.8 kb of ST313-GI carrying
st313-td was detected [12].
In the six genomes of isolates from Belarus (n = 2), China
(n = 2) and Nepal (n = 2) harbouring the st313-td gene and
analysed by whole genome sequencing in the present work, only
a fraction of ST313-GI was present. The ST313-GI fragments
differed in size between the strains tested: a fragment of 1467 bp
was detected in strains from Belarus, of 4245 bp in strains from
China, and of 11317 bp in strains from Nepal. Therefore, the
presence of the entire ST313-GI seems to be restricted to the S.
Typhimurium ST313 lineage circulating in sub-Saharan Africa.
Deletion of st313-td causes virulence attenuation in
systemic mice infection
In order to investigate whether st313-td plays a role in virulence,
the mutant strain, Dst313-td was tested in competition with the
wild type strain in a mouse model of systemic infection.
Interestingly, the deletion of st313-td decreased virulence in
C57/BL6 mice (CI: 0.0124; P value ,0.001) (Table 3). Introduc-
tion of the plasmid pAHF4 (encoding a cloned copy of the gene) to
the mutant in trans, restored, partly, the virulence to the wild type
level and removed significant differences between the two strains
(CI: 0.3340; P value .0.05) (Table 3). Besides, no significant
difference was found between the complemented and the WT
strains (P value .0.05). These data indicate that the increase in
virulence was indeed caused by the st313-td mutation. In contrast,
the CI of the mutant 4/74-C (harbouring st313-td) versus the WT
4/74 was slightly increased, yet not significantly (CI: 1.5251; P
value .0.05) (Table 3).
Virulence testing was based on competition for success between
WT and mutant in the same animal, as suggested by Beuzon et al.
[50] as a way to increase sensitivity in virulence testing since
mouse-to-mouse variation is minimized.
st313-td contributes to S. Typhimurium intracellular
survival within murine macrophages
Virulence of S. Typhimurium in the mouse model of systemic
disease was reduced in the absence of st313-td. In order to study
what might have caused this decrease, the ability of the mutant
and complemented strains to infect and survive inside J774
macrophages was analysed. In the macrophage experiments
where the strains were complement-opsonized, the WT 02–03/
002 showed significantly (P value ,0.05) less intracellular counts
at t = 1 h post-infection than the mutant isolate Dst313-td
(Figure 2A). On the other hand, no statistical significant
difference was observed between the WT 4/74 and the
construct, 4/74-C, nor between the three parental strains 02–
03/002, 4/74 and 14028.
After t = 20 h post-uptake, Dst313-td was significantly (3.5 fold)
reduced (P value ,0.05) compared to the WT 02–03/002.
Interestingly, at this time point, the WT 02–03/002 and the
complemented, 02-03/002-C, strains showed a similar net
replication of ,7 significantly higher than observed for the isolates
4/74 and 4/74-C (Figure 2C). Notably, no significant difference in
intracellular survival/replication was observed between the WT
Figure 3. Cytotoxicity towards J774 mouse macrophages. Measurement of cytotoxicity levels, A) at t = 1 h post-infection and B) t = 20 h post-
infection without opsonization, respectively. Strains tested for cytotoxicity were: S. Typhimurium WT 02–03/002, 4/74 and 14028 and the mutant
isolates: Dst313-td, 02-03/002-C (pAHF4, complemented strain), 4/74-C (pAHF4) and DssaV. The citotoxicity level is based on the release of LDH
(lactate dehydrogenase). The experiments were repeated at least four times with similar results and shown is an average of these. Errorbars indicate
standard deviation. Statistical significance was determined by one-way ANOVA analysis with pair-wise comparison of means.
doi:10.1371/journal.pone.0084566.g003
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4/74 and the mutant, 4/74-C, isolates at any time point post-
infection (Figure 2A and 2C).
In order to investigate whether opsonisation could affect the
uptake depending on the presence/absence of the gene st313-td,
similar experiments were conducted with no bacterial opsonisa-
tion. In this experiments, no significant difference (P value
.0.05) was observed between the WT 02/03–002 and the
mutant Dst313-td at 1 hour post challenge (Figure 2B) indicating
that the gene improves uptake by activated macrophages and/or
survival inside these cells. In these experiments intracellular
survival was also checked at time t = 20 h and the trend was the
same than in the assays where opsonisation was performed (not
shown).
The mutant in the SPI-2 gene ssaV which is attenuated for
macrophage survival [45] was included as control, and showed the
expected phenotype, as it was taken up to the same extend as the
WT strain, but showed reduced intracellular propagation
(Figure 2C).
It was also confirmed (P value .0.05) that the phenotype of the
WT 02/03–002 and 4/74 was not affected by the introduction of
the plasmid pACY177 used for complementation (data not
shown).
Theoretically, since cytotoxic effects results in exposure to the
antibiotic in such cell culture experiments, a strain with increased
multiplication ability could be masked by an increase in
cytotoxicity. However, the mutated strains did not differ signifi-
cantly from the WT in cytotoxicity 20 h post infection (P value
.0.05) (Figure 3B). Same results were observed at t = 1 post-
uptake where all the strains tested showed similar cytotoxicity
levels (Figure 3A).
st313-td is not needed for invasion of the epithelial cells
Infection of the intestinal epithelial layer is the first critical step
in Salmonella virulence. This aspect of infection was bypassed in
our mice experiments, since we used intra peritoneal challenge.
We therefore tested the role of st313-td in invasion in an
epithelial cell infection model. The gene st313-td was not
involved in invasion of the human epithelial INT-407 cells
(Figure 4) since its deletion did not change the ability of S.
Typhimurium to invade these cell lines compared to the WT,
whereas the control strain invH201::TnphoA, a S. Typhimurium
strain with a deficiency in T3SS1 [46], was decreased in this
phenotype (P value ,0.01). The presence of the plasmid
pACY177 in the WT strain 02–03/002 did not significantly (P
value .0.05) affect its invasion rate (not shown).
Discussion
A distinct genotype of S. Typhimurium, ST313, has emerged in
sub-Saharan Africa and might have adapted to cause potentially
fatal bacteraemia in humans. To better understand the underlying
virulence mechanisms and to identify the possible factors
responsible for its increased pathogenicity compared to other
clones of S. Typhimurium is of paramount importance for human
health.
A gene, st313-td, has recently been detected in the chromosomes
of the S. Typhimurium ST313 and S. Dublin isolates through
comparative genomics [12]. Pimlapas et al. [12] reported a total of
18 S. Typhimurium strains from DRC and Nigeria assigned to
ST313 carrying st313-td. The gene was harboured in a novel
putative pathogenicity island of ,18 kb in S. Typhimurium
ST313, termed ST313-GI [12].
In this study, we assessed the role of the gene of yet unknown
function, st313-td, in S. Typhimurium ST313 virulence by using in
vitro and in vivo experiments.
To study the role of st313-td in S. Typhimurium virulence, mice
experiments were performed. S. Typhimurium causes invasive
disease in the mouse and thus, this animal model is useful for
studying the role of the gene in systemic Salmonella infection.
Interestingly, an evident role of st313-td in systemic infection
was found and the WT 02–03/002 clearly outcompeted the
mutant Dst313-td. No significant increase in virulence was
observed for the mutant strain, 4/74-C (harbouring st313-td)
compared to the WT 4/74 however, its CI increased by 50%. The
data derived from mice experiments showed that the mutant,
Dst313-td, is significantly less pathogenic than the WT, suggesting
that st313-td contributes to virulence during the systemic infection
in mice. The results from the mice experiments performed with
the WT 4/74 and the mutant 4/74-C must be regarded as
inconclusive, but probably other factors (apart from this encoded
by st313-td) not present in WT 4/74 may be required to lead to an
increase in virulence.
Additionally, infection of mice macrophages and human
epithelial cell lines were performed to further detail the virulence
enhancing role of st313-td. These assays were considered relevant
because infection and intracellular survival in macrophages is
required for full virulence and infection of the intestinal epithelial
layer is the first critical step in Salmonella virulence [51,52].
Surprisingly, the lack of st313-td caused an increase on numbers of
intracellular bacteria in macrophages at t = 1 h post-infection, but
only in experiments where opsonisation was performed. This
indicates that st313-td influences the uptake and/or early survival
in macrophages but only in activated cells. Notably, in a previous
study it was demonstrated that S. Typhimurium D23580, assigned
to ST313 and carrying st313-td requires high levels of complement
for antibody-mediated bactericidal activity compared with S.
Typhimurium LT2 [19]. Thus, st313-td might play a role in
virulence by either decreasing the binding of the bacteria to
antibodies causing less uptake in macrophages or by diminishing
the susceptibility to complement mediated lysis. Further studies are
required to confirm this hypothesis.
Once inside the macrophages, lack of st313-td caused a
significantly decreased intracellular survival. It is well known that
Figure 4. Infection of the human epithelial Int407 cells. Invasion
of monolayes of Int407 cells was performed and invaded bacteria were
enumerated at t = 2 h post-infection. Strains tested were: S. Typhimur-
ium WT 02–03/002 and 4/74, and the mutant isolates: Dst313-td, 02-03/
002-C (pAHF4, complemented strain), 4/74-C (pAHF4) and in-
vH201::TnphoA. The experiments were repeated at least 4 times with
similar results and shown is an average of these. Error bars indicate
standard deviation. Statistical significance was determined by one-way
ANOVA analysis with pair-wise comparison of means.
doi:10.1371/journal.pone.0084566.g004
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Salmonella are facultative intracellular bacteria and their ability to
survive within cells is essential for virulence [53]. Therefore, the
gene st313-td appears to encode a factor that favours the
persistence of intracellular Salmonella. This trait may explain the
virulence enhancing effect in the mice studies. These data
indicate that the virulence enhancing role of st313-td appears to
be dual and related both to a decreased uptake of bacteria in
phagocytic cells and a better survival at late time points. Both
these phenotypes may add to a higher ability to cause systemic
infection, which is a hall mark of ST313. Results of cell culture
infection can be influenced by levels of toxicity, since bacteria
that kill the macrophages subject themselves to killing by
antibiotics in the media. It is therefore important to note that
strains tested in the macrophage infections showed similar
cytotoxicity levels at t = 20 h.
Contrary to the results using macrophages, deletion of st313-td
did not influence invasion of epithelial cells. Thus the function of
the gene product seems to be specific for phagocytic cells, and
hence only relevant for systemic infection.
Attempts to delete the whole genomic island ST313-GI were
performed several times as part of the current study with no
success. These data suggest that the carriage of ST313-GI in S.
Typhimurium ST313 is essential during the conditions used for
mutagenesis.
A strong association of the gene st313-td to isolates of S.
Typhimurium from cases of bacteraemia was observed by PCR
and furthermore, S. Dublin, which is a serovar highly invasive in
humans [54] was always found to carry st313-td. The gene was also
shown to be expressed in a collection of both S. Dublin and S.
Typhimurium strains. These data support a potential role of st313-
td in systemic salmonellosis caused by these serovars.
Taking into account that all the S. Dublin isolates proved to
harbour the gene, this serovar is a likely ancestor of the gene st313-
td, subsequently transferred to S. Typhimurium. Further analysis
should be performed in order to confirm this speculation and to
investigate whether it plays a role in S. Dublin virulence.
The presence of st313-td in a genetic mobile element, the
genomic island ST313-GI, supports our hypothesis that the gene
might have been transferred by horizontal gene transfer to S.
Typhimurium. It is noteworthy that Wain et al. [13] suggested that
S. Typhimurium ST313 likely emerged from a pathogen which
was already adapted to an animal host, causing diarrhoea in
healthy humans and invasive disease in HIV-infected patients as a
result of their immune deficiency.
The horizontal transfer of st313-td is also supported by the fact
that six strains isolated from human stools in Belarus and China,
and from water in Nepal assigned to other ST types (ST328, ST19
and ST328, respectively) than ST313 also carried the gene.
However, in contrast to the ST313 strains, the six non-ST313
isolates analysed did not harbour the entire ST313-GI and only
small portions of the genomic island matched the genomes of these
strains. Therefore, contrary to the situation observed for the single
gene st313-td, the genomic island ST313-GI appears to be
currently restricted to the clade ST313.
While ST313 has been specifically localized to the sub-
Saharan Africa, ST19 is the most commonly identified S.
Typhimurium sequence type and is globally predominating [10].
Both sequences types are circulating simultaneously in Kenya
[10] and co-circulation might allow genetic exchange and could
explain the spread of st313-td among the two clonal groups.
These results reveal that strains harbouring the gene are not
restricted to the clonal group ST313 and sub-Saharan Africa.
Recently, it has been suggested that birds might have been a
vehicle or source of S. Typhimurium ST313 [12], and if this is
true, a wider spread of the gene is to be expected.
Interestingly, st313-td was not detected in any S. Typhimurium
strain of food or animal origin. Thus, in S. Typhimurium, the
apparently restricted presence of st313-td in human isolates
suggests a potential host specificity for this gene as suggested for
its carrier, S. Typhimurium ST313. In a previous work, the
authors showed reduced genome in the S. Typhimurium ST313
strain D23580, in comparison to gastroenteritis strains, a finding
consistent with what might be expected of strains undergoing host
adaptation [12].
We demonstrated that a st313-td mutant displayed diminished
survival within J774 macrophages and was attenuated in virulence
in a systemic murine infection. Thus, this work adds another
chapter to understanding the virulence in S. Typhimurium but
also highlights the need for a closer monitoring of this sequence
type to control it and to avoid a further spread. Further work
should be carried out for a deepest characterization of the genomic
island and its possible essentiality in strains of ST313. Apart from
immunity studies, prevention of NTS bacteraemia also requires
genetic studies analysing the diversity of the circulating invasive
strains. These studies contribute to investigate the epidemiology
and transmission of this African pathogen, allow a better
understanding of the pathogenesis of the NTS disease and
represent key approaches for the developing of a much needed
vaccine as there are limited antibiotic choices against NTS
infections.
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